Sheila Schotzinger is an experienced manager in the biopharmaceutical industry, currently serving as ExM Manager at 2seventy bio since March 2022. Prior to this role, Sheila held various engineering positions at Merck from November 2015 to March 2022, contributing to vaccine manufacturing and process integrity through technical support, process optimization, and collaboration with cross-functional teams. Achievements include leading significant upgrades and investigations for vaccine products, executing change requests during audits, and improving operational reliability. Sheila's earlier experience includes quality oversight at Baxter Healthcare Corporation and laboratory roles at North Carolina State University and RTI International. Sheila holds a Bachelor of Science in Chemical and Biomolecular Engineering from North Carolina State University and a Master's degree in Engineering/Industrial Management from the University of Louisville.